News Image

CYTK INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics

Provided By PR Newswire

Last update: Oct 23, 2025

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their Options

Read more at prnewswire.com

CYTOKINETICS INC

NASDAQ:CYTK (10/31/2025, 8:00:01 PM)

After market: 63.59 0 (0%)

63.59

+1.34 (+2.15%)



Find more stocks in the Stock Screener

Follow ChartMill for more